Indivior Solutions Inc. will pay $289 million in fines for downplaying the safety risks of Suboxone, its drug for the treatment or opioid-use disorder, the Department of Justice said Thursday.
Indivior Solutions will also pay over $300 million in civil fines, bringing its total liability to $600 million, the DOJ said.
Suboxone, which contains the opioid buprenorphine, reduces withdrawal symptoms and opioid cravings in people addicted to opioids.
Indivior admitted in its plea to making false statements to the Massachusetts Medicaid program about the safety risks its Suboxone Film posed to children. The company’s goal was to convince MassHealth to ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.